1-El Backly R, Ulivi V, Tonachini L, Cancedda R, Descalzi F and Mastrogiacomo M. Platelet Lysate Induces In Vitro Wound Healing of Human Keratinocytes Associated with a Strong Proinflammatory Response; Tissue Engineering: Part A Volume 17, (13 and 14): 1787-1800, 2011.
2-Zaky SH, Ottonello A, Strada P, Cancedda R and Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med; 2: 472-481, 2008.
1-Additional references
1-Avanzini MA, Bernardo ME,Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Del Fante C, Ball LM. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord-blood and bone marrow-derived progenitors. Haematologica; 94 (12):1649-1660, 2009.
2-Bernardo ME, Avanzini MA , Perotti C, et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol; 211:121–130, 2007.
4-Bieback K, Hecker A, Kocaömer A, Lannert H, Schalmoser K, Strunk D, Klüter H, Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow. Stem Cells; 27:2331–2341, 2009.
5-Blande IS, Bassaneze V, Lavini-Ramos C, Fae CC, Kalil J, Miyakawa AA, Schettert IT and KriegerJE. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion; 49: 2680-2685, 2009.
6-Brunner D, Frank J, Appl H et al. Serum-free cell culture: the serum-free media interactive online database. ALTEX; 27, 53-62, 2010.
7-Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, Mico C, Rambaldi A, Golay J and Introna M. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplantation; 40:785–791, 2007.
8-Carrancio S, Lopez-Holgado C, Sanchez-Guijo FM, Villarona E, Barbadoa V, Tabera S, Diez-Campelo M, Blanco J, San Miguel JF andConsuelo del Canizo M, Experimental. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Hematology; 36:1014–1021, 2008.
9-Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Regeneration of meniscus cartilage in a knee treated percutaneoulsy implanted autologous mesenchymal stem cells. Med Hypotheses; 71: 900-908, 2008.
10-Chan RK, Liu P, Lew DH et al..Expired liquid preserved platelet releasates retain proliferative activity. J Surg Res; 126, 55-58, 2005.
11-Chen B, Sun HH, Wang HG, Kong H, Chen FM, Yu Q. The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars. Biomaterials; in press Apr 17,2012
12.Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood; 103: 2096–2104, 2004.
13-Crespo-Diaz
R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J, Dietz AB and Terzic A.
Platelet Lysate Consisting of a Natural Repair Proteome Supports Human
Mesenchymal Stem Cell Proliferation and Chromosomal Stability. Cell
Transplantation; Vol. 20, pp. 797–811, 2011
14-Dahl JA, Duggal S, Coulston N et al. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum; Int J Dev Biol; 52:1033–1042, 2008.
15-Davenport M, Verrier S, Droeser R et al. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue; Tissue Eng Part A; 15 :869–875, 2009.
16-Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol;205: 228-236, 2005.
17-ESAC (2008). Statement on the use of FCS and other animal- derived supplements. http://ecvam.jrc.it
18-Falkner E, Appl H, Eder C, Losert UM, Schöffl H and Pfaller W. Serum free cell culture: The free access online database. Toxicol In Vitro; 20: 395-400, 2006.
19-Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy; 14(5):540-54, 2012.
20-Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF,Rudakowa SF, Luria` EA et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol; 2: 83–92,1974.
21-Frou SJ. The development, benefits and disadvantages of serum-free media. Dev Biol Stand; 99, 157-166, 1999.
22-Giacco
F, D’Agostino E, Fratellanza G, Perna E, Misso S, Saldalamacchia G, Oriente F,
Fiory F, Miele C, Formisano S, Beguinot F and Formisano P. Thrombin-activated
platelets induce proliferation of human skin fibroblast by stimulating autocine
production of insulin-growth factor. FASEB J; 20:2402-2404, 2006.
23-Honn KV, Singley JA, Chavin W. Fetal bovine serum: A multivariate standard.
Proc Soc Exp Biol Med; 149:344–347, 1975.
24-Italiano JE Jr, Richardson JL, Patel-Hett S et al. Angiogenesis is regulated by a novel mechanism: Pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood; 111:1227–1233, 2008.
25-Jayme DW, Epstein DA and Conrad DR. Fetal bovine serum alternatives.Nature; 334: 547-548, 1988.
26-Johansson, l., Klinth, J., Holmqvist, O., and Ohlson, S.. Platelet lysate: a replacement for fetal cell culture? Cytotechnol; 42: 67-74, 2003.
27-Jochems CEA, van der Valk JBF, Stafleu FR and Baumans V. The use of fetal bovine serum: ethical or scientific problem? ATLA; 30: 219-227, 2002. Kakudo N . Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg; 122: 1352-1360, 2008.
28-Kaps C, Loch A, Haisch A et al.Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput; 40:485-490, 2002.
29-Kobayashi T, Watanabe H, Yanagawa T et al. Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. J Bone Joint Surg Br;87:1426–1433, 2005.
30-Kocaömer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells; 25:1270-1278, 2005.
31-Lange C, Cakiroglu F, Spiess A, Cappalo-Obermann H, Zander A. Platelet lysate for rapid expansion of human mesenchymal stromal cells. Cell Ther Transplant; 1 (2): 49-53, 2008
32-Lin HT, Tarng YW, Chen YC et al. Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc; 37:4504–4505, 2005.
33-Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, Grünert A and Bachem MG. Platelet-Derived Growth Factors Stimulate Proliferation and Extracellular Matrix Synthesis of Pancreatic Stellate Cells: Implications in Pathogenesis of Pancreas Fibrosis. Lab Invest; 80 (1): 47-55,2000.
34-Mannello F, Tonti GA. Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells; 25:1603–1609, 2007.
35-Müller AM, Davenport M, Verrier S, Droeser R, Alini M, Bocelli-Tyndall , Schaefer DJ, Martin I and Scherberich A. Platelet Lysate as a Serum Substitute for 2D Static and 3D Perfusion Culture of Stromal Vascular Fraction Cells from Human Adipose Tissue .Tissue Engineering: Part A;15, 4 :869-875, 2009.
36-Müller I, Kordowich S, Holzwarth C et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy; 8:437–444, 2006.
37-Ogino Y, Ayukawa Y, Kukita T and Koyano K. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in plate- let-rich plasma to the proliferation of osteoblast-like cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 101, 724-729, 2006.
38-Prins HJ, RozemullerH, Vonk-Griffioen S, Verweij VGM, Dhert WJA,Slaper-Cortenbach ICM and Martens ACM. Bone-Forming Capacity of Mesenchymal Stromal Cells When Cultured in the Presence of Human Platelet Lysate as Substitute for Fetal Bovine Serum.Tissue Engineering Part A; 15, 12:3741-3759, 2009.
39-Rauch C, Feifel E, Schöffl H, Pfaller W, Gstraunthaler G. Alternatives to the use of fetal bovine serum: Platelet lysates as serum replacement in cell and tissue culture. ALTEX ; 24(4): 353, 2007.
40-Reichl H, Balen A, Jansen CA. Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins? Hum Reprod; 17:2501–2508, 2007.
41-Reinisch A, Rohde E, Schallmoser K,Bjelic-Radisic, Lanzer G, Linkesch W and Strunk D. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med; 2(4): 371-382, 2007.
42-Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion; 47:1436-1446, 2007.
43-Schallmoser K, Rohde E, Reinisch A et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods; 14: 185–196, 2008.
44-Schallmoser K, Strunk D. Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal-Free Human Stem Cell Cultures. J Vis Exp, 32: 1-10,2009.
45-Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells; 23: 1357-1366, 2005.
46-Spreafico A, Chellini F, Frediani B et al.. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J. Cell. Biochem; 108, 1153-1165, 2009.
47-Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol; 32:1212-1225, 2004.
48-Umeno Y, Okuda A, Kimura G, Proliferative behavior of fibroblasts in plasma –rich culture medium. J Cell Sc ; 94 : 567-575, 1989.
49-van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, Hellebrekers L, Hyllner J, Jonker FH, Prieto P, Thalen M and Baumans V. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol. In Vitro; 18: 1-12, 2004.
50-Von Bonin M, Stolzel F, Goedecke A et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant; 43:245–251, 2009.
51-Wessman SJ and Levings RL. Benefits and risks due to animal serum used in cell culture pro- duction. Dev Biol Stand; 99, 3-8, 1999.
2-References on Growth Factors in Anti-Wrinkles Therapy:
1-Bhanot S, Alex JC. Current applications
of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;
18(1):27-33, 2002.
2-Cho
JM, Lee YH, Baek RM, Lee SW. Effect of platelet-rich plasma on ultraviolet
b-induced skin wrinkles in nude mice. JPRAs; 64: e31-e39, 2011.
3-Fitzpatrick
RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot
study. J Cosmet Laser Ther; 5(1): 25-34, 2003.
4-Man
D, Plosker H, Winland-Brown JE. The use of autologous platelet rich plasma
(platelet gel) and autologous platelet poor plasma (fibrin glue) in cosmetic
surgery. Plast Reconstr Surg; 107(1): 229-239, 2001.
5-Welsh
WJ. Autologous platelet gel-clinical function and usage in plastic surgery.
Cosmetic Derm ; 13:13–18, 2000.
3-References on Growth Factors in
Cosmetics:
1-Mehta
RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatologic
Therapy; Published online; DOI: 10.1111/j.1529-8019.2007.00149.x,2007.
2-Michael
H. Gold MD, Mitchel P. Goldman MD, Julie Biron Efficacy of Novel Skin Cream
Containing Mixture of Human Growth Factors and Cytokines for Skin Rejuvenation.
Journal of Drugs in Dermatology; 6 (2):197-202, 2007.
3-Sundaram
H, Mehta RC, Norine JA, Kircik L, Cook-Bolden FE et al. Topically applied
physiologically balanced growth factors: a new paradigm of skin rejuvenation.
J. Drugs Dermatol ; 8(5 Suppl Skin Rejuvenation):4-13, 2009.
4-References
on Growth Factors in Alopecia:
1-Bernstein
RM et al. The aesthetics of follicular transplantation. Dermatol Surg;
23:785-799, 1997.
2-Bernstein
RM et al. The art of repair in surgical hair restoration part 1: basic repair
strategies.Dermatol Surg; 28: 783-794, 2002.
3-Du
Toit DF et al. Soft and hard-tissue augmentation with platelet-rich plasma:
Tissue culture dynamics, regeneration and molecular biology perspective.
International Journal of Shoulder Surgery; 1: 64-73, 2007.
4-Du
Toit DF et al. Shoulder surgeon and autologous cellular regeneration (ACR)-from
bench to bed; Part 1-the link between the human fibroblast, connective tissue
disorders and shoulder. International Journal of Shoulder Surgery; 1, 3 :
87-95, 2007.
5-Eppley BL, Pietrzak WS, Blanton W. Platelet-rich plasma: A review of biology
and applications in plastic surgery. Plast Reconstr Surg; 18:147E-159C, 2006.
6-Ebstein
JS. Revision surgical hair restoration: repair of undesirable results. Plast
Reconstruct Surg; 104: 222-232, 1999.
7-Greco
JF et al. A “ crush study” review of micrograft survival. Dermatol Surg;
23:752-755, 1997.
8-Hwang
S et al. Does the recipient site influence the hair growth characteristics in
hair transplantation. Dermatol Surg; 28: 795-8, 2002.
9-Kierszenbaum
AL. Histology and cell biology. An introduction to pathology, Mosby, St Louis ;
106-108, 2002.
10-Kumar
V, Cotran RS, Robbins SL. Robbins Basic Pathology. 7th edit. , Saunders,
Philadelphia ; 74-75, 2002.
11-Marx
RE, Garg AK. Dental and Craniofacial applications of platelet-rich plasma.
Quintessence books, Chicago; 1-154, 2005.
12-
Mazzucco L et al. Platelet rich plasma and platelet gel preparation using
Plateltex®; Vox Sanguinis; 1: 1-7, 2008.
13-Pietrzak
WS, Eppley BL. Platelet-rich plasma. Biology and new technology. J.
Craniofacial Surg; 16:1043-1054, 2005.
14-Pietrzak
WS, Yuehuei H, Qian K, Harry AD, Ehrens CH. Platelet-Rich and Platelet poor
plasma: Development of an animal model to evaluate hemostatic efficacy. Cranial
Facial Surgery; 18 : 559-566, 2007.
5-References
on Growth Factors in Dentistry:
1-Abernathy
W et al. Nonmetallic Fixation in Elective Maxillofacial Surgery. AORN Journal;
71:193-198, 2000.
2-Anitua
E. Plasma rich in growth factors: preliminary results of use in the preparation
of future sites for implants. J Oral Implantol;14:529–535,1999.
3-Artzi
ZC, Newmcovsky C. The Application of Deproteinized Bovine Bone Mineral for
Ridge Preservation Prior to Implantation. Clinical and Histological
Observations in a Case Report. Journal of Periodontal; 69:1062-1067, 1998.
4-Ashman
A. Ridge Preservation – The Future Practice of Dentistry, Dental Economics;
80-83, 1995.
5-Bahat
O et al. Preservation of Ridges Utilizing Hydroxyapatite, The International
Journal of Periodontics and Restorative Dentistry; 35-41, 1987.
6-Bell
D. Particles Versus Solid Forms of Hydroxyapatite As A Treatment Modality To
Preserve Residual Alveolar Ridges, The Journal of Prosthetic Dentistry;
56:323-326, 1986.
7-Carlson
NE, Roach Jr RB. Platelet-rich plasma: Clinical applications in dentistry. JADA;
133 (10):1383-1386, 2002.
8-Danesh-Meyer
MJ, Filstein MR, Shanaman R. Histological evaluation of sinus augmentation
using platelet rich plasma (PRP): a case series. J Int Acad Periodontol;
3(2):48-56, 2001.
9-Frourn
SJ, Tarnow DP. Wallace SS, Rohner MD, Cho SC. Sinus Floor Elevation Using An
organic Bovine Bone Matrix (OsteoGraf/N) with and Without Autogenous Bone: A
clinical, Histologic, Radiographic, and Histomorphometric Analysis-Part 2 of an
Ongoing Prospective Study. The International Journal of Periodontics &
Restorative Dentistry; 18:529-544, 1998.
10-Frourn
SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet rich plasma on bone
growth and osseointegration in human maxillary sinus grafts: three bilateral
case reports. Int J Periodont Restor Dent;22(1):45-53, 2002.
11-Garg
AK. Chapter 5 - Grafting Materials in Repair and Restoration, Tissue
Engineering – Applications in Maxillofacial Surgery and Periodontics, 83-101. Garg
AK et al. Using Platelet-Rich Plasma to Develop Bone Grafts, Dental Implants
and Periodontics. Dental Implantology Update; 11: 41-44, 2000.
12-Garg
AK et al. The Use of Platelet-Rich Plasma to Enhance the Success of Bone Grafts
Around Dental Implants. Dental Implantology Update; 11:17-20, .2000.
13-Garg
AK et al. Using Platelet-Rich Plasma to Develop an Autologous Membrane for
Growth Factor Delivery in Dental Implant Therapy. Dental Implantology Update;
11:41-44, 2000.
14-Garg
AK. Lateral Proximal Tibia Bone Harvest for Use in Augmentation Procedures.
Dental Impantology Update; 11(5): 33-40, 2001.
15-Garg
AK. Bone Induction With and Without Membranes and Using Platelet-Rich Plasma.
Oral and Maxillofacial Clinics of North America; 13 (3):437-448, 2001.
16-Graziani
F et al. In vitro effects of different concentration of PRP on primary bone and
gingival cell lines. Preliminary results. Minerva Stomatol; 54:15-22, 2005.
17-Gross
J. Ridge Preservation Using HTR Synthetic Bone Following Tooth Extraction.
General Dentistry; 43 (4): 364-367,1995.
18-Hoen
M et al. Preserving the Maxillary Anterior Alveolar Ridge Contour Using
Hydroxyapatite. JADA; 118:739-741, 1989.
19-Irwin
C. Polypeptide growth factors-a role in restorative dentistry? Eur J
Prosthodont Restor Dent;3(5):227-30, 1995.
20-Kaigler
D, Avila G, Wisner-Lynch L, Nevins ML, Nevins M, Rasperini G, Lynch SE,
Giannobile WV. Platelet-derived growth factor applications in periodontal and
peri-implant bone regeneration. Expert Opin Biol Ther; 11(3):375-85, 2011.
21-Kassolis
JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing
platelet-rich plasma in combination with freeze-dried bone allograft: case
series. JPeriodontol;71:1654–1661,2000.
22-Kim
SG, Chung CH, Kim YK, Park JC, Lim SC. Use of particulate dentin-plaster of
Paris combination with/without platelet rich plasma in the treatment of bone
defects around implants. Int J Oral Maxillofac Implant ; 17(1):86-94, 2002
22-Landesberg
R et al. Quantification of Growth Factor Levels Using a Simplified Method of
Platelet-Rich Plasma Gel Preparation. Journal of Oral & Maxillofacial
Surgery; 58:297-300, 2000.
23-Landesberg
R et al. Risks of Using Platelet Rich Plasma Gel. Journal of Oral Maxiofacial
Surgery; 56:1116-1117, 1998.
24-Lekovic
V et al. Preservation of Alveolar Bone in Extraction Sockets Using
Bioabsorbable Membranes. Journal of Periodontal; 69:1044-1049, 1998.
25-Loo
WD. Ridge preservation with immediate treatment dentures. Immediate dentures
for Ridge preservation; 5-11, 1968.
26-Lozada
JL, Caplanis N, Proussaefs P, Kammeyer G. Platelet-Rich Plasma Application in
Sinus Graft Surgery: Part I-Background and Processing Techniques. Clinical;
38-42, 2001.
27-Marx
RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE and Georgeff KR:
Platelet-rich plasma, growth factor enhancement for bone grafts. Oral Surgery
Oral Medicine Oral Pathol; 85: 638-646, 1998.
28-Marx
RE, Garg AK. Bone Structure, Metabolism, and Physiology: Its Impact on Dental
Implantology. Implant Dentistry; 7:267-276, 1998.
29-Marx
RE. Platelet-Rich Plasma: A Source of Multiple Autologous Growth Factors for
Bone Grafts, In: Lynch SE, Genco RJ, Marx RE (eds). Tissue Engineering:
Applications in Maxillofacial Surgery and Periodontics.Chicago:
Quintessence:71-82,1999.
30-Marx
RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent
;10:225–228,2001.
31-Marx
RE. Platelet-rich plasma. Evidence to support its use. J Oral Maxillofac Surg;
62:489-496, 2004.
32-Misch
CM, Misch CE. Chapter 31 – Intraoral Autogenous Donor Bone Grafts for Implant
Dentistry. Contemporary Implant Dentistry. 2nd ed., 497-508.
33-Murray
CG, Adkins KF.The elective retention of vital roots for alveolar bone
preservation a pilot study. J. Oral Surgery; 650-656, 1979.
34-Nemcovsky
CE, Serfaty V. Alveolar Ridge Preservation Following Extraction of Maxillary
Anterior Teeth. Report on 23 Consecutive Cases. Journal of Periodontal;
67:390-395, 1996.
35-
Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its
application in oral surgery: literature review. Tissue Eng Part B
;14(3):249-58, 2008.
36-Okuda
K et al .Platelet-rich plasma contains high level of platelet-derived growth
factors and transforming growth factor beta and modulates the proliferation of
periodontally related cells in vitro. J Periodontol; 74: 849-857, 2003.
37-Peleg
M, Mazor Z, Garg AK. Augmentation Grafting of the Maxillary Sinus and Simultaneous
Implant Placement in Patients with 3 to 5 mm of Residual Alveolar Bone Height.
The International Journal of Oral & Maxillofacial Implants; 145-156, 1999.
38-Petrungaro
P. The Use of Platelet Rich Plasma with Growth Factor (Autologous Platelet Gel)
to Enhance Hard and Soft Tissue Healing and Maturation in Surgical Implant
Dentistry. Contemporary Periodontics and Implantology; 1 (8): 2000.
39-Petrunagaro
P.The Use of Platelet Rich Plasma with Growth Factors (Autologous Platelet Gel)
to Enhance Hard and Soft Tissue Healing and Maturation in the Reconstruction of
the Maxillary Pneumatized Sinus. Contemporary Periodontics and Implantology; 1
(9): February-March 2001.
40-Petrungaro
PS. Using platelet-rich plasma to accelerate soft tissue maturation in esthetic
periodontal surgery. Compend Contin Educ Dent ;22(9):729–736,2001.
41-Petrungaro
P.Immediate Restoration of Dental Implants in the Aesthetic Zone, Dental
Implantology Update; 12 (12), December 2001.
42-Rodriquez
A, Anastassov G, Lee H, Buchbinder D, Wettan H.Maxillary sinus Augmentation
With Deproteinated Bovine Bone and Platelet Rich Plasma With simultaneous
Insertion of Endosseous Implants. American Association of Oral and
Maxillofacial Surgery;61:157-163,2003.
43-Petrungaro
P. Platelet-Rich Plasma for Dental Implants and Soft-Tissue Grafting. Dental
Implantology Update; 11 (6): 41-46, 2001.
44-Quinn
J et al. Preservation of the Alveolar Ridge With Hydroxyapatite Tooth Root
Substitutes. JADA; 110:189-193, 1985.
45-Quinn
J, Kent J.Alveolar Ridge Maintenance With Solid Nonporous Hydroxyapatite, The
International Journal of Periodontics and Restorative Dentistry ; 35-41, 1987.
46-Raghoebar
GM, Schortinghuis J, Liem RS, Ruben JL, van der Wal JE, Vissink A. Does
platelet-rich plasma promote remodeling of autologous bone grafts used for
augmentation of the maxillary sinus floor? Clin Oral Implants Res; 16:349-356,
2005.
47-Robiony
M, Polini F, Costa F, Pasca M and Politi M: Vertical augmentation in severe
atrophic mandible: osteogenesis distraction and platelet-rich plasma (PRP). Rivista Italiana
Chirurgia Maxillo-Facciale; 12: 3-7, 2001.
48-Robiony M,
Polini F, Costa F, et al. Osteogenesis distraction and platelet-rich
plasma for bone restoration of the severely atrophic mandible: preliminary results.
J Oral Maxillofac Surg ;60:630–635,2002.
49-Rosenberg
ES, Torosion J. Sinus Grafting Using Platelet-Rich Plasma – Initial Case
Presentation. Pract
Periodont Aesthet Dent; 12(9): 843-850, 2000.
50-Scala M,
Gipponi M, Margarino G, Mereu P, Orsi A and Strada P: Platelet concentrate in
maxillofacial surgery. Proc American Academy Maxillofacial
Prosthetics. International Congress Maxillofacial Prosthetics, Maxillofacial
Prosthetics in the 21st Century, Kauai, Hawaii, pp. 132, 2000.
51-Scala
M, Gipponi M, Pasetti S, Dellachá E, Ligorio M, Villa G, Margarino G, Giannini
G, Strada P. Clinical applications of autologous cryoplatelet gel for the
reconstruction of the maxillary sinus. A new approach for the treatment of
chronic oro-sinusal fistula. In Vivo; 21(3):541-547, 2007.
52-Sclar
A.Preserving Alveolar Ridge Anatomy Following Tooth Removal In Conjunction With
Immediate Implant Placement – The Bio-Col Technique. Atlas of the Oral and
Maxillofacial Surgery Clinics of North America; 7:39-59, 1999.
53-Sclar
A.Use Of The Epithelialized Palatal Graft With Dental Implants. Atlas of the
Oral and Maxillofacial Surgery Clinics of North America; 7:79-94, 1999.
54-Seibert
JS, Salama H. Alveolar Ridge Preservation and Reconstruction. Periodontology
2000;11:69-84, 1996.
55.
Shashikiran ND, Reddy VV,Yavagal CM, Zakirulla M. Applications of platelet-rich plasma
(PRP) in contemporary pediatric dentistry. J Clin Pediatr Dent ; 30(4):283-6,
2006.
56-Shanaman
R, Filstein MR, Danesh-Meyer MJ. Localized ridge augmentation using GBR and
platelet-rich plasma: case reports.Int J Periodontics Restorative Dent;
21:345–355,2001.
57-Soffer
E, Ouhayoun JP, Anagnostou F. Fibrin sealants and platelet preparations in bone
and periodontal healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod ;
95:521–528,2003.
58-Sonnleitner
D, Huemer P, Sullivan DY. A Simplified Technique for Producing Platelet-Rich
Plasma and Platelet Concentrate for Intraoral Bone Grafting Techniques: A
Technical Note. International Journal of Oral & Maxillofacial Implants;
15:879-882, 2000.
59-Stefani
CM, Machado MAN.Platelet-Derived Growth Factor/Insulin-Like Growth Factor-1
Combination and Bone Regeneration Around Implants Placed Into Extraction
Sockets: A Histometric Study in Dogs. Implant Dentistry; 126-130, 2000.
60-Tyler
SA.Office-Based Harvest of Platelet-Rich Plasma for Intraoral Bone Grafting,
Poster 34, AAOMS, 2000.
61-Whitman
DH et al. A Technique for Improving the Handling of Particulate Cancellous Bone
and Marrow Grafts Using Platelet Gel. Journal of Oral Maxiofacial Surgery,;
45:1217-1218,198.
62-Whitman
DH et al.Platelet Gel: An Autologous Alternative to Fibrin Glue with
Applications in Oral and Maxillofacial Surgery. Journal Oral Maxillofacial
Surgery; 55:1294-1299, 1997.
25-Whitman
DH, Berry RL and Green DM. Platelet gel: an alternative to fibrin glue with
applications in oral and maxillofacial surgery. J Oral Maxillo-Facial Surg; 55:
1294-1299, 1997.
6-References on Growth Factors in Wound healing and Orthopedic Surgery:
6.1 - Humans:
1-Adler
SC, Kent KJ. Enhancing healing with growth factors. Facial Plast Surg Clin
North Am;10(2):129-146, 2002.
2-Alsousou
J, Thompson M, Hulley P, Noble A, Willet K. The biology of platelet-rich plasma
and its application in trauma and orthopaedic surgery: a review of the
literature. J Bone Joint Surg Br ; 91(8):987-996,2009.
3-Anitua
E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of
proteins for healing and tissue regeneration. Thromb Haemost ; 91(1):4-15,
2004.
4-Anitua
E, Andia I, Sánchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P,
Nurden AT.Autologous preparations rich in growth factors promote proliferation
and induce VEGF and HGF production by human tendon cells in culture.J Orthop
Res ; 23:281–286,2005.
5-Anitua
E, Sánchez M, Nurden AT, et al. Platelet-released growth factors enhance the
secretion of hyaluronic acid and induce hepatocyte growth factor production by
synovial fibroblasts from arthritic patients. Rheumatology (Oxford);
46(12):1769-1772, 2007.
6-Anitua
E, Sánchez M, Nurden AT, Nurden P, Orive G, Andia I.New insights into and novel
applications for platelet-rich fibrin therapies. Trends Biotechnol 24:227–234,
2006.
7-Anitua
E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Azofra J, Andia I.
Reciprocal actions of platelet secreted TGF-beta1 on the production of VEGF and
HGF by human tendon cells. Plast Reconstr Surg 119:950–959,2007.
8-Arpornmaeklong
P, Kochel M, Depprich R, Kübler NR, Würzler KK. Influence of platelet-rich
plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An
in vitro study. Int J Oral Maxillofac Surg 33:60–70,2004.
9-Aspenberg
P. Stimulation of tendon repair: mechanical loading, GDFs and platelets. A
mini-review. Int Orthop 31:783–789,2007.
10-Aspenberg
P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair
in rats. Acta Orthop Scand 75:93–99,2004.
11-Barrientos
s, Stojanovic O, Golinko MS, Brem H and Tomic-Canic M. Growth factors and
cytokines in wound healing. Wound Repair Regen ; 16: 585-601,2008.
12-Barrett
S, Erredge S. Growth factors for chronic plantar fascitis.Podiatry Today;
7:37-42, 2004.
13-Bennett
NT, Schultz GS. Growth factors and wound healing: biochemical
properties
of growth factors and their receptors. Am JSurg ;165(6):728-737,1993.
14-Bennett
NT and Schultz GS: Growth factors and wound healing: Part II. Role in normal
and chronic wound healing. Am J Surg; 166: 74-81, 1993.
15-Berghoff
W, Pietrzak W, Rhodes R. Platelet-rich plasma application during closure
following total knee arthroplasty. Orthopedics ;29(7):590-598, 2006.
16-Crovetti
G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic
wounds. Transfus Apher Sci ; 30(2):145-151, 2004.
17-Cullinane
AB, O’Callaghan P, McDermott K, Keohane C, Cleary PE. Effects of autologous
platelet concentrate and serum on retinal wound healing in an animal model. Graefe’s Arch Clin
Exp Ophthalmol ; 240(1):35-41, 2002.
18-Dallari D,
Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use
of bone grafts supplemented with platelet gel or platelet gel and bone marrow
stromal cells. J
Bone Joint Surg Am ;89(11):2413-2420, 2007.
19-Delrossi
AJ, Cernaianu AC, Vertrees RA, et al. Platelet-rich plasma reduces
postoperative blood loss. J Thorac Cardiovasc Surg;100(2):281-286, 2000.
20-De
Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch
GJ. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports
Med; 36(6):1171-1178, 2008.
21-de
Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for
chronic Achilles tendinopathy: a randomized controlled trial. JAMA ;
303(2):144-149, 2010.
22-Driver
VR, Hanft J, Fylling CP, Beriou JM. Autologel Diabetic Foot Ulcer Study Group.
A prospective, randomized, controlled trial of autologous platelet-rich plasma
gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage ;
52(6):68-70,2006.
23-Edwards
S, Calandruccio J. Autologous blood injections for refractory lateral epicondylitis.
J
Hand Surg Am ; 28(2):272-278, 2003.
24-Eppley
BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from
platelet-rich plasma: implications for wound healing. Plast Reconstr Surg;
114(6):1502-1508, 2006.
25-Everts
PA, Devilee RJ, Brown Mahoney C, et al. Platelet gel and fibrin sealant reduce
allogenic blood transfusions in total knee arthroplasty. Acta Anaesthesiol
Scand ; 50(5):593-599, 2006.
26-Frechette
JP, Martineau I, Gagnon G. Platelet rich plasmas: growth factor content and
roles in wound healing. J Dent Res ; 84(5):434-439, 2005.
27-Fufa
D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma
using soluble type I collagen. J Oral Maxillofac Surg ;66(4):684-690, 2008.
28-Gamradt
SC, Rodeo SA, Warren RF. Platelet rich plasma in rotator cuff repair. Tech
Orthop ; 22:26-33, 2007.
29-Gandhi
A, Doumas C, O’Connor JP, Parsons JR, Lin SS. The effects of local platelet
rich plasma delivery on diabetic fracture healing. Bone ; 38:540-546, 2006.
30-Gardner
MJ, Demetrakopoulos D, Klepchick P, Mooar P. The efficacy of autologous
platelet gel in pain control and blood loss in TKR: an analysis of the
haemoglobin, narcotic requirement and range of motion. Int Orthop;
31:309-313,2007.
31-Han
B, Woodell-May J, Ponticiello M, Yang Z, Nimni M. The effect of thrombin
activation of platelet-rich plasma on demineralized bone matrix
osteoconductivity. J Bone Joint Surg Am ;91(6): 1459-1470, 2009.
32-Ganio
C, Tenewitz FE, Wilson RC, Moyles BG. The treatment of chronic nonhealing
wounds using autologous platelet-derived growth factors. J Foot Ankle Surg ;
32(3):263-8, 1993.
33-Govindarajan
B, Shah A, Cohen C, et al.Malignant transformation of human cells by
constitutive expression of platelet-derived growth factor-BB. J Biol Chem; 280
(14):13936-13943.
34-Greenhalgh
DG: The role of growth factors in wound healing. J Trauma Injury Infection
Critical Care ; 41: 159-167, 1996.
35-Hammond
JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich
plasma to treat muscle strain injuries. Am J Sports Med ; 37(6):1135- 1142,
2009.
36-Henderson
JL, Cupp CL, Ross EV, et al. The effects of autologous platelet gel on wound
healing. Ear Nose Throat J ; 82(8):598-602, 2003.
37-Hiramatsu
T, Okamura T, Imai Y, et al. Effects of autologous platelet concentrate
reinfusion after open heart surgery in patients with congenital heart disease.
Ann Thorac Surg ; 73(4):1282–1285, 2002.
38-Kajikawa
Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, Nagae M, Arai Y,
Kawata M, Kubo T. Platelet-rich plasma enhances the initial mobilization of
circulation-derived cells for tendon healing. J Cell Physiol; 215(3):837-845,
2008.
39-Kasemkijwattana
C, Menetrey J, Bosch P, et al. Use of growth factors to improve muscle healing
after strain injury. Clin Orthop Relat Res ; 370:272-285, 2000.
40-Kanno
T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma
enhances human osteoblast-like cell proliferation and differentiation. J Oral
Maxillofac Surg ; 63(3):362-369, 2005.
41-Kazakos
K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP
gel as an aid in the management of acute trauma wounds. Injury; 40(8):801-805,
2009.
42-Kitoh
H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Transplantation of culture
expanded bone marrow cells and platelet rich plasma in distraction osteogenesis
of the long bones. Bone;40(2):522-528, 2007.
43-Knighton
DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of
chronic nonhealing wounds. Successful treatment with autologous
platelet-derived wound healing factors (PDWHF). Ann Surg ; 204(3):322-330,
1986.
44-Knighton
DR, DoucetteM, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet
derived wound healing formula in human clinicaltrials. Prog Clin Biol Res
; 266:319-329, 1988.
45-Kon E,
Filardo G, Delcogliano M, et al. Platelet-rich plasma: new clinical
application. A pilot study for treatment of jumper’s knee. Injury ;
40(6):598-603,2009.
46-Krupski
WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective
randomized trial of autologous platelet-derived wound healing factors for
treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg;
14(4):526-532, 1991.
47-Kunimoto
BT. Growth factors in wound healing:the next great innovation? Ostomy Wound
Manage ; 45(8):56-64, 1999.
48-Lindeboom
JA, Mathura KR, Aartman IH, Kroon FH, Milstein DM, Ince C. Influence of the
application of platelet-enriched plasma in oral mucosal wound healing. Clin
Oral Implants Res ; 18(1):133-139, 2007.
49-Lynch
SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor
in wound healing: synergistic effects with other growth factors. Proc Natl Acad
Sci USA; 84(21):7696-7700, 1987.
50-Lynch
SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and
synergistic effects on partial thickness porcine skin wounds. J Clin Invest ;
84: 640– 646, 1989.
51-Margolis
DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate
for the treatment of diabetic neuropathic foot ulcers. Diabetes Care;
24(3):483-8, 2001.
52-Margolis
DJ, Bartus C, Hoffstad O, Malay S, Berlin JA. Effectiveness of recombinant human
platelet-derived growth factor for the treatment of diabetic neuropathic foot
ulcers. Wound Repair Regen ; 13(6):531-536, 2005.
53-Marx
RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR.
Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod ; 85(6):638-646, 1998.
54-
Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant
Dent ; 10(4):225-228, 2001.
55-Marx
RE. Platelet-rich plasma: evidence to support its use. J O Growth Factors;
24(3):165-171, 2006.
56-McAleer
JP, Sharma S, Kaplan EM, Persich G. Use of autologous platelet concentrate in a
nonhealing lower extremity wound. Adv Skin Wound Care; 9(7):354-363, 2006.
57-Mehta
S, Watson JT. Platelet rich concentrate: basic science and current clinical
applications. J Orthop Trauma ; 22(6):432-438. 2008.
58-Menetrey
J, Kasemkijwattana C, Day CS, et al. Growth factors improve muscle healing in
vivo. J Bone Joint Surg Br. 2000;82(1):131-137.
59-Mishra
A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich
plasma.Am J Sports Med; 34(11):1774-1778, 2006.
60-Mishra
A, Woodall J Jr, Vieira A.Treatment of Tendon and Muscle using platelet-rich
plasma, Clin Sports Med; 28(1):113-125,2009.
61-Mishra
A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich
plasma. Clin Sports Med ; 28(1):113-125, 2009.
62-Molloy
T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament
healing. Sports Med ;33(5):381-394, 2003.
63-Nagumo
A, Yasuda K, Numazaki H, et al. Effects of separate application of three growth
factors (TGF-beta 1, EGF, and PDGF-BB) on mechanical properties of the in situ
frozen-thawed anterior cruciate ligament. Clin Biomech ; 20(3):283-290, 2005.
64-Nurden
AT,Nurden P, Sanchez M, Andia I and Anitua E. Platelets and wound healing.Front
Biosci; 13:3532-3548,2008.
65-O’Connell
SM, Impeduglia T, Hessler K, Wang XJ, Carroll RJ, Dardik H. Autologous
platelet-rich fibrin matrix as cell therapy in the healing of chronic
lower-extremity ulcers. Wound Repair Regen; 16(6):749-756, 2008.
66-Orrego
M, Larrain C, Rosales J, et al. Effects of platelet concentrate and a bone plug
on the healing of hamstring tendon in a bone tunnel. Arthroscopy ;
24(12):1373-1380, 2008.
67-Pietramaggiori
G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP. Freeze-dried platelet-rich
plasma shows beneficial healing properties in chronic wounds.Wound Repair Regen
; 14(5):573-580, 2006.
68-Sampson
S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for
musculoskeletal injuries: a review. Curr Rev Musculoskeletal Med ;
1(3-4):165-174, 2008.
69-Randelli
PS, Arrigoni P, Cabitza P, Volpi P, Maffulli N. Autologous platelet rich plasma
for arthroscopic rotator cuff repair: a pilot study. Disabil Rehabil;
30(20-22):1584-1589, 2008.
70-Reboa G,
Gipponi M, Testa T, Giannini G, Scala M, Dalla Costa R, Strada P. Regenerative
medicine for the definitive surgical repair of pilonidal sinus. A new
method of wound reconstruction. In Vivo; 21(3):529-534, 2007.
71-Robson
MC, Phillips LG, Thomason A, et al. Recombinant human platelet-derived growth
factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg ;
29(3):193-201, 1992.
72-Roukis
TS et al. Autologous platelet-rich plasma for wound and osseous healing. A
review. Adv ther; 23: 218-237, 2006.
73-Rozman
P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue
injuries. Acta
Dermatovenerol Alp Panonica Adriat;16(4):156-165, 2007.
74-Salemi S,
Rinaldi C, Manna F, Guarneri GF, Parodi PC. Reconstruction of
lower leg skin ulcer with autologous adipose tissue and platelet-rich plasma. J
Plast Reconstr Aesthet Surg ; 61(12):1565-1567, 2008.
75-Sánchez
M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically
repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports
Med; 35(2):245-251, 2007.
76-Sánchez
M, Anitua E, Cugat R, et al. Nonunions treated with autologous preparation rich
in growth factors. J
Orthop Trauma ; 23(1):52-59, 2009.
77-Savarino
L, Cenni E, Tarabusi C, et al. Evaluation of bone healing enhancement by
lyophilized bone grafts supplemented with platelet gel: a standardized
methodology in patients with tibial osteotomy for genu varus. J Biomed Mater
Res B Appl Biomater; 76(2):364-372, 2006.
78-Schmidt
MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor
and platelet derived growth factor on in vivo cartilage healing and repair.
Osteoarthritis Cartilage ; 14(5):403-412, 2006.
79-Schnabel
LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic
gene expression patterns in flexor digitorum superficialis tendons. J Orthop
Res; 25(2):230-240, 2007
80-Shah
M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, and Roberts A.
Role of elevated plasma transforming growth factor- beta1 levels in wound
healing. Am J Pathol ; 154: 1115–1124, 1999.
81-Shimo
T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K,
Takemura M, Matsumara T, Takigawa M. Connective tissue growth factor induces
the proliferation, migration, and tube formation of vascular endothelial cells
in vitro, and angiogenesis in vivo. J Biochem ; 126: 137–145, 1999.
82-Silva
A, Sampaio R. Anatomic ACL reconstruction: does the platelet-rich plasma
accelerate tendon healing? Knee Surg Sports Traumatol Arthrosc ; 17(6):676-682,
2009.
83-Steed
DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized
prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102
activated platelet supernatant, topical versus placebo. Diabetes Care ;
15(11):1598-1604, 1992.
84-Steed
DL. Clinical evaluation of recombinant human platelet-derived growth factor for
the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J
Vasc Surg; 21(1):71-78, 1995.
85-Steed
DL. Modifying the wound healing response with exogenous growth factors. Clin
Plast Surg ; 25: 397–405, 1998.
86-Virchenko
O, Aspenberg P. How can one platelet injection after tendon injury lead to a
stronger tendon after 4 weeks? Interplay between early regeneration and
mechanical stimulation. Acta Orthop ; 77(5):806-812, 2006.
87-Vogt
PM, Lenhardt M, Wagner D, Jansen V, Krieg M, Steinau HU. Determination of
endogenous growth factors in human wound fluid: temporal presence and profiles
of secretion. Plast Reconstr Surg ; 102: 117–123, 1998.
88-Werner
S. Keratinocyte growth factor: a unique player in epithelial repair
processes.Cytokine Growth Factor ; Rev 2: 153–165, 1998.
89-Woodall
J Jr, Tucci M, Mishra A, Benghuzzi H. Cellular effects of platelet rich plasma:
a study on HL-60 macrophage-like cells, Biomed Sci Instrum; 43:266-271, 2007.
90-Wrotniak
M, Bielecki T, Gazdzik TS. Current opinion about using the platelet-rich gel in
orthopaedics and trauma surgery. Ortop Traumatol Rehabil ; 9(3):227-238, 2007.
91-Wu W, Zhang J, Dong Q, Liu Y, Mao T, Chen F. Platelet-rich plasma: a
promising cell carrier for micro-invasive articular cartilage repair. Med
Hypotheses ; 72(4):455-457, 2009.
92-Yamada
Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone
for regeneration with mesenchymal stem cells and platelet-rich plasma:
tissue-engineered bone regeneration. Tissue Eng; 10:955-964, 2004.
93-Yu
W, Naim JO, Lanzafame RJ. Expression of growth factors in early wound healing
in rat skin. Lasers
Surg Med ; 15: 281–289, 1994.
6.2
- Animals (Horses):
1-Bosch
G, Moleman M, Barneveld A, van Weeren PR, van Schie HT. The effect of
platelet-rich plasma on the neovascularization of surgically created equine
superficial digital flexor tendon lesions. Scand J Med Sci Sports ;
21(4):554-561, 2011.
2-Bosch
G, René van Weeren P, Barneveld A, van Schie HT. Computerised analysis of
standardised ultrasonographic images to monitor the repair of surgically
created core lesions in equine superficial digital flexor tendons following
treatment with intratendinous platelet rich plasma or placebo. Vet J ;
187(1):92-98, 2011.
3-Bosch
G, van Schie HT, de Groot MW, Cadby JA, van de Lest CH, Barneveld A, van Weeren
PR. Effects of platelet-rich plasma on the quality of repair of mechanically
induced core lesions in equine superficial digital flexor tendons: A
placebo-controlled experimental study. J Orthop Res ; 28(2):211-217, 2010.
4-Carter
CA, Jolly DG, Worden CE Sr., et al. Platelet-rich plasma gel promotes
differentiation and regeneration during equine wound healing. Exp Mol Pathol;
74:244–255,2003.
5-Del
Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S. Equine adipose-tissue
derived mesenchymal stem cells and platelet concentrates: their association in
vitro and in vivo. Vet Res Commun ; 32 Suppl 1:S : 51-55, 2008.
6-DeRossi
R, Coelho AC, Mello GS, Frazílio FO, Leal CR, Facco GG, Brum KB. Effects of
platelet-rich plasma gel on skin healing in surgical wound in horses.
Acta
Cir Bras ; 24(4):276-281, 2009.
7-Fennis
JPM, Stoelinga PJW, Jansen JA. Mandibular reconstruction:a clinical and
radiographic animal study on the use of autogenous scaffolds and platelet-rich
plasma. J Oral Maxillofac Surg;31:281–286,2002.
8-Geburek
F, Stadler P. [Regenerative therapy for tendon and ligament disorders in
horses. Terminology, production, biologic potential and in vitro effects].
Tierarztl Prax Ausg G Grosstiere Nutztiere ; 39(6):373-383. 2011. German
9-Torricelli
P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A, Kon E, Giardino R.
Regenerative medicine for the treatment of musculoskeletal overuse
injuries
in competition horses. Int Orthop ; 35(10):1569-1576, 2011.
10-Textor
JA, Norris JW, Tablin F. Effects of preparation method, shear force, and
exposure to collagen on release of growth factors from equine platelet-rich
plasma.
Am J Vet Res ; 72(2):271-278, 2011.
11-McCarrel
T, Fortier L. Temporal growth factor release from platelet-rich plasma,
trehalose lyophilized platelets, and bone marrow aspirate and their effect on
tendon and ligament gene expression. J Orthop Res ; 27(8):1033-1042, 2009.
12-Schnabel
LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier
LA. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in
flexor digitorum superficialis tendons. J Orthop Res ; 25(2):230-240,2007.
13-Schnabel
LV, Sonea HO, Jacobson MS, Fortier LA. Effects of platelet rich plasma and
acellular bone marrow on gene expression patterns and DNA content of
equine
suspensory ligament explant cultures. Equine Vet J ; 40(3):260-265, 2008.
14-Waselau M,
Sutter WW, Genovese RL, Bertone AL. Intralesional injection of
platelet-rich plasma followed by controlled exercise for treatment of midbody
suspensory
ligament desmitis in Standardbred racehorses. J Am Vet Med Assoc
15;232(10):1515-1520, 2008.
15-Zhang
YZ, Da WM. [Experimental study of platelet-rich plasma optimizing mesenchymal
stem cells culture]. Zhonghua Xue Ye Xue Za Zhi (Chinese Journal of
Hematology); 27(6):403-405, 2006. Chinese.
16-Smith
JJ, Ross MW, Smith RK. Anabolic effects of acellular bone marrow, platelet rich
plasma, and serum on equine suspensory ligament fibroblasts in
vitro.
Vet
Comp Orthop Traumatol; 19(1):43-47, 2006.